Cargando…
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma
Fibrolamellar hepatocellular carcinoma (FLC) is a usually lethal primary liver cancer driven by a somatic dysregulation of protein kinase A. We show that the proteome of FLC tumors is distinct from that of adjacent nontransformed tissue. These changes can account for some of the cell biological and...
Autores principales: | Levin, Solomon N., Tomasini, Michael D., Knox, James, Shirani, Mahsa, Shebl, Bassem, Requena, David, Clark, Jackson, Heissel, Søren, Alwaseem, Hanan, Surjan, Rodrigo, Lahasky, Ron, Molina, Henrik, Torbenson, Michael S., Lyons, Barbara, Migler, Rachael D., Coffino, Philip, Simon, Sanford M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284549/ https://www.ncbi.nlm.nih.gov/pubmed/37343102 http://dx.doi.org/10.1126/sciadv.adg7038 |
Ejemplares similares
-
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022) -
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based study
por: Berkovitz, Amichai, et al.
Publicado: (2022) -
Arginine limitation drives a directed codon-dependent DNA sequence evolution response in colorectal cancer cells
por: Hsu, Dennis J., et al.
Publicado: (2023) -
Human liver organoids for disease modeling of fibrolamellar carcinoma
por: Narayan, Nicole J.C., et al.
Publicado: (2022) -
Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012)